The chemical class designated as LRRC52 Activators includes substances that are capable of upregulating the expression or augmenting the activity of the leucine-rich repeat-containing protein 52 (LRRC52). These activators may exert their influence by engaging with transcription factors, thereby enhancing the transcriptional output of the LRRC52 gene. They could also modify the epigenetic markers associated with the gene's regulatory regions, for instance, by inhibiting the activity of histone deacetylases, leading to a more transcriptionally active chromatin state, or by obstructing the action of DNA methyltransferase enzymes, preventing gene silencing through DNA methylation.
Beyond influencing gene expression, these activators may also operate post-translationally, altering the protein's stability, its localization within the cell, or its interaction with other proteins. Since LRRC52 plays a pivotal role in modulating the activity of potassium channels, particularly through its interactions with the Slo3 potassium channel, these activators could have a significant impact on this interaction, which is critical for the channel's function. These chemical activators may range from small molecule ligands to complex biological macromolecules, each characterized by their unique binding sites, affinity, and specificity towards the LRRC52 protein or its regulatory elements. By interacting with LRRC52 or its modulators, these compounds may induce conformational changes in the protein or alter its expression levels, thus modulating its activity within the cellular environment. This class of compounds encompasses a diverse range of potential mechanisms and structures, unified by their common goal of modulating LRRC52.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
May increase cAMP levels, potentially leading to activation of PKA and upregulation of LRRC52. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
HDAC inhibitor that could increase LRRC52 expression through chromatin remodeling. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Could demethylate DNA and potentially activate the LRRC52 gene. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Might modulate gene expression, possibly affecting LRRC52 indirectly. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which could lead to transcriptional changes increasing LRRC52. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another HDAC inhibitor that could potentially enhance LRRC52 expression. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that might mimic forskolin's potential effect on LRRC52. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Could influence Wnt signaling and indirectly affect LRRC52 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in gene regulation, could potentially upregulate LRRC52 in specific cellular contexts. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can influence transcription factor activity, potentially affecting LRRC52 expression. | ||||||